These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 36359844
21. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Jaarsma D, Haasdijk ED, Grashorn JA, Hawkins R, van Duijn W, Verspaget HW, London J, Holstege JC. Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261 [Abstract] [Full Text] [Related]
23. Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulation. Graber DJ, Cook WJ, Sentman ML, Murad-Mabaera JM, Sentman CL. Cytotherapy; 2024 Feb; 26(2):126-135. PubMed ID: 38043051 [Abstract] [Full Text] [Related]
24. CXCR2 Is Deregulated in ALS Spinal Cord and Its Activation Triggers Apoptosis in Motor Neuron-Like Cells Overexpressing hSOD1-G93A. La Cognata V, D'Amico AG, Maugeri G, Morello G, Guarnaccia M, Magrì B, Aronica E, D'Agata V, Cavallaro S. Cells; 2023 Jul 09; 12(14):. PubMed ID: 37508478 [Abstract] [Full Text] [Related]
25. Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome. Martin LJ, Wong M. Front Neurol; 2020 Jul 09; 11():592851. PubMed ID: 33381076 [Abstract] [Full Text] [Related]
26. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Gento-Caro Á, Vilches-Herrando E, Portillo F, González-Forero D, Moreno-López B. Brain Pathol; 2022 May 09; 32(3):e13022. PubMed ID: 34585475 [Abstract] [Full Text] [Related]
27. Treatment with Herbal Formula Extract in the hSOD1G93A Mouse Model Attenuates Muscle and Spinal Cord Dysfunction via Anti-Inflammation. Yang EJ, Lee SH, Cai M. Mediators Inflamm; 2022 May 09; 2022():4754732. PubMed ID: 35832305 [Abstract] [Full Text] [Related]
28. Early deficits in GABA inhibition parallels an increase in L-type Ca2+ currents in the jaw motor neurons of SOD1G93A mouse model for ALS. Venugopal S, Ghulam-Jhelani Z, Ahn IS, Yang X, Wiedau M, Simmons D, Chandler SH. Neurobiol Dis; 2023 Feb 09; 177():105992. PubMed ID: 36623607 [Abstract] [Full Text] [Related]
29. Subpial delivery of adeno-associated virus 9-synapsin-caveolin-1 (AAV9-SynCav1) preserves motor neuron and neuromuscular junction morphology, motor function, delays disease onset, and extends survival in hSOD1G93A mice. Wang S, Ichinomiya T, Savchenko P, Wang D, Sawada A, Li X, Duong T, Li W, Bonds JA, Kim EJ, Miyanohara A, Roth DM, Patel HH, Patel PM, Tadokoro T, Marsala M, Head BP. Theranostics; 2022 Feb 09; 12(12):5389-5403. PubMed ID: 35910808 [Abstract] [Full Text] [Related]
30. The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS). Lee NY, Kim Y, Ryu H, Kang YS. Biochem Biophys Res Commun; 2017 Jan 29; 483(1):135-141. PubMed ID: 28043791 [Abstract] [Full Text] [Related]
31. Bojungikgi-tang Improves Muscle and Spinal Cord Function in an Amyotrophic Lateral Sclerosis Model. Cai M, Lee SH, Yang EJ. Mol Neurobiol; 2019 Apr 29; 56(4):2394-2407. PubMed ID: 30030751 [Abstract] [Full Text] [Related]
32. Assessment of metal concentrations in the SOD1G93A mouse model of amyotrophic lateral sclerosis and its potential role in muscular denervation, with particular focus on muscle tissue. Enge TG, Ecroyd H, Jolley DF, Yerbury JJ, Kalmar B, Dosseto A. Mol Cell Neurosci; 2018 Apr 29; 88():319-329. PubMed ID: 29524628 [Abstract] [Full Text] [Related]
33. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice. Rao MV, Campbell J, Palaniappan A, Kumar A, Nixon RA. J Neurochem; 2016 Apr 29; 137(2):253-65. PubMed ID: 26756888 [Abstract] [Full Text] [Related]
34. Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation. Liu X, Zhang J, Li J, Song C, Shi Y. Mol Metab; 2022 Sep 29; 63():101536. PubMed ID: 35772643 [Abstract] [Full Text] [Related]
35. Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice. Chen K, Northington FJ, Martin LJ. Brain Struct Funct; 2010 Mar 29; 214(2-3):219-34. PubMed ID: 19888600 [Abstract] [Full Text] [Related]
36. Secreted Metabolome of ALS-Related hSOD1(G93A) Primary Cultures of Myocytes and Implications for Myogenesis. Stella R, Bonadio RS, Cagnin S, Andreotti R, Massimino ML, Bertoli A, Peggion C. Cells; 2023 Nov 30; 12(23):. PubMed ID: 38067180 [Abstract] [Full Text] [Related]
37. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Bonifacino T, Cattaneo L, Gallia E, Puliti A, Melone M, Provenzano F, Bossi S, Musante I, Usai C, Conti F, Bonanno G, Milanese M. Neuropharmacology; 2017 Sep 01; 123():433-445. PubMed ID: 28645622 [Abstract] [Full Text] [Related]
38. Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice. Xu G, Ayers JI, Roberts BL, Brown H, Fromholt S, Green C, Borchelt DR. Hum Mol Genet; 2015 Feb 15; 24(4):1019-35. PubMed ID: 25305079 [Abstract] [Full Text] [Related]
39. Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells. López-González R, Kunckles P, Velasco I. Cell Transplant; 2009 Feb 15; 18(10):1171-81. PubMed ID: 19660174 [Abstract] [Full Text] [Related]
40. ALS-linked SOD1 mutations impair mitochondrial-derived vesicle formation and accelerate aging. Guo Y, Guan T, Yu Q, Sanghai N, Shafiq K, Li M, Jiao X, Na D, Zhang G, Kong J. Redox Biol; 2024 Feb 15; 69():102972. PubMed ID: 38056310 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]